Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Butoctamide hydrogen succinate calcium salt
RN: 32266-82-3
UNII: ONA8W17G6J
InChIKey: VRSFOTUXFICGLW-UHFFFAOYSA-L

Classification Codes

  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formula

  • C32-H58-N2-O10.Ca

Molecular Weight

  • 668.8764
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Butoctamide hydrogen succinate calcium salt

Synonyms

  • Butoctamide hydrogen succinate calcium salt
  • Calcium N-2-ethylhexyl-beta-oxybutyramide semisuccinate
  • Succinic acid, monoester with N-(2-ethylhexyl)-3-hydroxybutyramide, calcium salt (2:1)
  • UNII-ONA8W17G6J

Systematic Name

  • Butyramide, N-(2-ethylhexyl)-3-hydroxy-, succinate (monoester), calcium salt (2:1)

Registry Numbers

CAS Registry Number

  • 32266-82-3

FDA UNII

  • ONA8W17G6J

Related Registry Number

  • 32838-28-1 (Parent)

System Generated Number

  • 0032266823

Molecular Formulas

Molecular Formula

  • C32-H58-N2-O10.Ca

Molecular Formula Fragments

  • C32-H58-N2-O10
  • Ca
  • COMPONENT

Structure Descriptors

InChI

1S/2C16H29NO5.Ca/c2*1-4-6-7-13(5-2)11-17-14(18)10-12(3)22-16(21)9-8-15(19)20;/h2*12-13H,4-11H2,1-3H3,(H,17,18)(H,19,20);/q;;+2/p-2

InChIKey

VRSFOTUXFICGLW-UHFFFAOYSA-L

Smiles

C(=O)(CCC(=O)[O-])OC(CC(=O)NCC(CCCC)CC)C.C(=O)(CCC(=O)[O-])OC(CC(=O)NCC(CCCC)CC)C.[Ca+2]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 476mg/kg (476mg/kg)   United States Patent Document. Vol. #3639457,
mouse LD50 oral 2129mg/kg (2129mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 579, 1970.
mouse LD50 subcutaneous 1187mg/kg (1187mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 579, 1970.
rat LD50 intraperitoneal 741mg/kg (741mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 579, 1970.
rat LD50 oral 5746mg/kg (5746mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 579, 1970.
rat LD50 subcutaneous 3037mg/kg (3037mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 579, 1970.